Salute e Benessere
Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership
This collaboration strengthens Bionical Emas' position as a trusted supply partner and highlights its continued success in forging impactful global alliances. As the sole distributor, Bionical Emas will streamline access to Pharma Resources' oncology portfolio for pharmaceutical companies, CROs, and clinical trial providers worldwide.
The agreement comes at a crucial time, with 5-Fluorouracil shortages disrupting cancer treatments and clinical trials across Europe . Bionical Emas' global infrastructure and agile supply model will cut delivery times from months to weeks, ensuring faster, more reliable access to essential medications. By combining advanced demand forecasting with proactive inventory strategies, Bionical Emas and Pharma Resources are addressing long-standing supply chain challenges –accelerating trial timelines and improving flexibility for investigational sites.
All clinical trial enquiries should be sent to: pharmaresources@bionicalemas.com
Notes to Editors
Bionical Emas is a global Clinical Trial Supply (CTS) and Early Access Programs (EAP) group bringing life-changing medicines to patients around the world. Their range of services and capabilities, benefit many of the world's leading pharma and biotech companies.
bionicalemas.com
Pharma Resources GmbH, based in Hameln, Germany , is a specialized company in the pharmaceutical industry focusing on generic oncology products. It provides a full-service solution—from regulatory approval to delivery—ensuring reliable and high quality supply chains.
Products - Products
View original content:https://www.prnewswire.co.uk/news-releases/bionical-emas-and-pharma-resources-announce-exclusive-global-clinical-trial-supply-partnership-302467513.html